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Bacteria respond to elevated osmolality by the accumulation of a range of low molecular weight molecules, known
as compatible solutes (owing to their compatibility with the cells' normal physiology at high internal
concentrations). The neonatal pathogen Cronobacter sakazakii is uniquely osmotolerant, surviving in powdered
infant formula (PIF) which typically has a water activity (aw) of 0.2 – inhospitable to most micro-organisms. Mortality
rates of up to 80% in infected infants have been recorded making C. sakazakii a serious cause for concern. In silico
analysis of the C. sakazakii BAA-894 genome revealed seven copies of the osmolyte uptake system ProP. Herein, we test
the physiological role of each of these homologues following heterologous expression against an osmosensitive
Escherichia coli host.
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Cronobacter spp. (previously Enterobacter sakazakii) are
Gram-negative, motile, facultatively anaerobic food-
bourne pathogens belonging to the Enterobacteriacea
family [1]. The Cronobacter genus, which has become
increasingly diverse in recent years, comprises ten spe-
cies: Cronobacter sakazakii, Cronobacter malonaticus,
Cronobacter turicensis, Cronobacter universalis, Crono-
bacter muytjensii, Cronobacter dublinensis, Cronobacter
condiment, Cronobacter pulveris, Cronobacter helveticus
and Cronobacter zurichensis [2,3]. Cronobacter sakazakii
is an opportunistic pathogen capable of causing severe
clinical symptoms in adults, infants and elderly patients
(FAO/WHO 2008). The most at risk group are pre-term,
low birth weight neonates who can suffer life-threatening
necrotizing enterocolitis, meningitis and septeceamia, with
resulting mortality rates of 40-80% [4]. In a recent study
multilocus sequence typing revealed that the majority of
meningitis cases in neonates are caused as a result of in-
fection with one clonal lineage, C. sakazakii ST4 clonal
complex [2]. While a significant proportion of infants suc-
cumb to the infection within days of birth [5], survivors
often suffer severe neurological damage [6].* Correspondence: roy.sleator@cit.ie
Department of Biological Sciences, Cork Institute of Technology, Rossa
Avenue, Bishopstown, Cork, Ireland
© 2014 Feeney et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.While studies have identified plant material (in particular
vegetables, fruits, cereals and rice) as the most likely source,
foods such as wheat, cheese, meat, herbs and spices have
also been found to harbour the pathogen [7]. However, it is
the presence of C. sakazakii in powdered infant formula
(PIF) which is cause for most concern (FAO/WHO 2008).
Indeed, PIF has been epidemiologically linked with several
major outbreaks of C. sakazakii infection [8]. Although iso-
lated at low levels, persistence of the pathogen for extended
periods, in some cases for up to 2.5 years [9] makes C.
sakazakii a particularly formidable pathogen. Given that
pasteurisation has been shown to effectively inactivate C.
sakazakii, the presence of the organism in PIF can be at-
tributed to contamination resulting from the addition of
contaminated ingredients and/or the use of non-sterile
equipment either during processing or reconstitution [10].
Survival of C. sakazakii in PIF, which has an aw of ~ 0.2
(significantly below the normal cut off of 0.4 for canonical
microbial growth), suggests that the pathogen is uniquely
armed with an extensive array of stress survival mecha-
nisms necessary to overcome this otherwise inhospitable
environment [11]. Indeed, a previous in silico analysis of
C. sakazakii BAA-894 (a strain originally isolated from
powdered infant formula [12]) revealed 53 putative osmo-
tolerance loci, including both hyper- and hypo-osmotic
stress response systems. Interestingly, while C. sakazakii
harbours homologues of all the principal osmotoleranceLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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C. sakazakii possesses multiple copies of certain osmoto-
lerance mechanisms; including seven copies of the E. coli
proP homologue, each of which potentially encodes a sep-
arate osmolyte uptake system.
Herein, we describe the functional analysis of the putative
osmotolerance loci ESA_02131, ESA_01706, ESA_04214,
ESA_pESA3p05450, ESA_00673 and ESA_03328, when
heterologously expressed against E. coli MKH13 (an osmot-
ically sensitive mutant). Furthermore, given that the C.
sakazakii osmotic stress response is likely regulated at the
level of DNA expression [11], we analysed the transcrip-
tional response of each of the proP homologues following
osmotic up-shock.
Materials and methods
Bacterial strains, plasmids and growth conditions
Bacterial strains and plasmids used in this study are listed
in Table 1. C. sakazakii BAA-894 and E. coli DH5α clones
were grown at 37°C in LB broth (Sigma-Aldrich Co.). E.
coli MKH13 strains were grown in LB or M9 minimal
medium containing 0.5% glucose, 0.04% arginine, 0.04%
isoleucine, 0.04% valine (Sigma-Aldrich Co.). After filter
sterilization, proline or glycine betaine (Sigma-Aldrich
Co.) was added to M9 to a final concentration of 1 mM.
Ampicillin was made up as a concentrated stock solutionTable 1 Bacterial strains and plasmids
Strain or plasmid Relevant genotype or characteristics
Plasmids
pUC18 Ampr, lacZ', pMB9 replicon
pUC18::ESA_02131 pUC18 with ESA_02131 gene under cont
pUC18::ESA_01706 pUC18 with ESA_01706 gene under cont
pUC18::ESA_04214 pUC18 with ESA_04214 gene under cont
pUC18::ESA_pESA3p05450 pUC18 with ESA_pESA3p05450 gene und
pUC18::ESA_01226 pUC18 with ESA_01226 gene under cont
pUC18::ESA_00673 pUC18 with ESA_00673 gene under cont
pUC18::ESA_03328 pUC18 with ESA_03328 gene under cont
Strains
Cronobacter sakazakii BAA-894 C.sakazakii strain isolated from powdered
Escherichia coli DH5α Intermediate cloning host.supE44 ΔlacU169
MKH13 MC4100Δ(putPA)101Δ(proP)2Δ(proU)
MKH13 pUC18::ESA_02131+ Host strain harbouring pUC18: ESA_02131
MKH13 pUC18::ESA_01706+ Host strain harbouring pUC18: ESA_01706
MKH13 pUC18::ESA_04214+ Host strain harbouring pUC18: ESA_04214
MKH13 pUC18::ESA_pESA3p05450+ Host strain harbouring pUC18: ESA_pESA
MKH13 pUC18::ESA_01226+ Host strain harbouring pUC18: ESA_01226
MKH13 pUC18::ESA_00673+ Host strain harbouring pUC18: ESA_00673
MKH13 pUC18::ESA_03328+ Host strain harbouring pUC18: ESA_03328
Ampr - This strain is resistant to ampicillin.and added to media at the required levels. Medium osmo-
larity was adjusted using NaCl.
In silico analysis of C. sakzakii BAA-894
Putative proP loci were identified using a homology
based transfer approach, as described previously [11].
Further in silico analysis was carried out with the aid of
the Lasergene suite of applications (DNASTAR, Madison,
USA) and Simplicity [16] (nSilico, Cork, Ireland).
DNA manipulations and sequence analysis
Genomic DNA was extracted from C. sakazakii as de-
scribed by Sambrook et al. [17]. Plasmid DNA was isolated
with the High Pure Plasmid Isolation Kit (Roche Diagnos-
tics). PCR primers (Table 2) were designed for each proP
homologue based on C. sakazakii strain BAA-894 sequence
data available from the NCBI database (NC_009778.1). All
PCR reactions were carried out using the high fidelity Vel-
ocity DNA polymerase Kit (Bioline) in accordance with
manufacturer's instructions. The Ta of each reaction was
dependent on the Tm of individual primers. Negative con-
trol reaction mixtures were included with sterile nuclease
free water in place of template DNA. Restriction enzymes
and T4 DNA ligase were purchased from Roche Diagnos-
tics (Mannheim, Germany). Each restriction digest and T4
ligation reaction was carried out as per the manufacturer'sSource or reference
[13]
rol of native promoter This work
rol of native promoter This work
rol of native promoter This work
er control of native promoter This work
rol of native promoter This work
rol of native promoter This work
rol of native promoter This work
formula associated with neonatal intensive care unit [12]
(80lacZΔM15)R17 recA1 endA1 gyrA96 thi-1 relA1. Invitrogen.
[15]
plasmid. Ampr. This work
plasmid. Ampr. This work
plasmid. Ampr. This work
3p05450 plasmid. Ampr. This work
plasmid. Ampr. This work
plasmid. Ampr. This work
plasmid. Ampr. This work
Table 2 Primers
Primer name Primer sequence (5' to 3') Length Characteristics
ESA_02131 F CATCGGCCGACAGGCCAGTCAATGAATGATGC 32 Eag1cut site
R CATTCTAGAGAGTACAACGGAATGCGGGG 29 Xba1 cut site
ESA_01706 F CATTCTAGAGTCGGGCGGCTCTTTATCTGG 30 Xba1 cut site
R CATGGATCCTTGACCAGATGACGCAGTCTTTC 32 BamH1 cut site
ESA_04214 F CATGAATTCGTCTCTTTCTGTGCCAACTATCTGC 34 EcoR1 cut site
R CATTCTAGACTACCTGACGCGTACCCTGTATATC 34 Xba1 cut site
ESA_pESA3p05450 F CATGAATTCATCATCTCTACACGCTGCCTTCTG 33 EcoR1 cut site
R CATTCTAGATCTCCACCTGCGCCTCTATC 29 Xba1 cut site
ESA_01226 F CATGAATTCCAGTGCGCCGGAGCTTTTCG 29 EcoR1 cut site
R CATTCTAGAGGGCTGTCGGTTGACGAAATTAAAC 34 Xba1 cut site
ESA_00673 F CATGAATTCTAAAAGCGAAATCCTCCCGTACTGGC 35 EcoR1 cut site
R CATGGATCCCCTGCAAAGCATCGCCGATTACC 32 BamH1 cut stie
ESA_03328 F CATTCTAGATCGCTATCGCTGACCGTGAAATG 32 Xba1 cut site
R CATGGATCCTGCTGAACGAACAGTATGGCCG 31 BamH1 cut site
pUC18 MCS Check F CATTAG CTC ACT CAT TAG GCA CC 20 pUC18 insert check
R CATTGT AAA ACG ACG GCC AGT G 19 pUC18 insert check
RTESA_02131 F GCTGGCGTGTATCGGTCT 18 Probe 31
R CTC GGC ATA TAA GTA AGC AGC AT 23 Probe 31
RTESA_01706 F CGA CGG TCA TTC TGC TCA C 19 Probe 32
R AGC AGG CCA ATC TGA TGG TA 20 Probe 32
RTESA_04214 F GCA TAA ACG CGC CCT GTA 18 Probe 18
R TTA GCG AAG AAG AAG CCG ATA 21 Probe 18
RTESA_01226 F GGG TAT CAG GTG GCA AGC 18 Probe 70
R GTA AAT CGC GAC CGT ATG C 19 Probe 70
RTESA_00673 F CCG GAC AGA TAA ACC GTC AC 20 Probe 11
R GAC GAG GCA CCG ACA ATC 18 Probe 11
RTESA_03328 F CGT GCC GTT CGT AAT GGT 18 Probe 29
R AAC GAA ATG CCG GTA AAG C 19 Probe 29
RTESA_pESA3p05450 F TGG TGG CGA TTT CCA ACT 18 Probe 71
R CCC GAA ACG GTC AGA AAG 18 Probe 71
RT16S F TGT AGC GGT GAA ATG CGT AG 20 Probe 65
R AGC GTC AGT CTT CGT CCA G 19 Probe 65
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thermocycler block to ensure optimal temperature con-
ditions. Plasmid pUC18 was used as the cloning plat-
form; with individual vectors being constructed for the
expression of each gene under the control of its own na-
tive promoter. The integrity of each C. sakazakii gene
was confirmed by sequencing (MWG Operon, Germany
and GATC, Germany). Electrocompetent E. coli DH5α
were obtained from New England Biolabs and E. coli
MKH13 was made electrocompetent using the method
outlined by Sambrook and Russell [17]. Electrotransfor-
mation was carried out using standard methods.Gene expression analysis (qRT-PCR)
Total RNA was isolated (Roche High Pure RNA Isola-
tion Kit) from C. sakazakii grown in a shaking incubator at
37°C prior to osmotic shock and up to 2 hours post shock
with 6% NaCl. RNA quantity and quality was confirmed by
microphotometry (Nanodrop, De, USA). Complementary
DNA (cDNA) was synthesised using 1 μg total RNA incu-
bated with 50pM of random hexamer primers followed by
a 20 μl reverse transcription reaction using the Bioloine
cDNA synthesis kit, as per manufacturer’s instructions
(Bioline). The amplification conditions used were 42°C for
1 hour, 70°C for 15 min and 4°C for 5 min. PCR primers
Figure 1 Gene expression analysis of each proP homologue in C.
sakazakii BAA-894 when subject to osmotic stress with 6%
added NaCl.
Feeney et al. Gut Pathogens 2014, 6:15 Page 4 of 9
http://www.gutpathogens.com/content/6/1/15and probes were designed using the Universal Probe
Library Assay Design Centre (http://lifescience.roche.com/
shop/home) and are summarised in Table 2. Optimisation
of the gene expression assay was carried out on each pri-
mer/probe set by varying the concentration of either primer
or probe to achieve the best signal. Based on these results,
individual primer/probe mixes were made for each gene of
interest. Amplification reactions contained 5 μl cDNA,
10 μl of the Light Cycler 480 probes Master 2x conc
(Roche) and 2 μl primer/probe mix in a total reaction of
20 μl. All reactions were performed in triplicate using 96
well plates on the Roche LightCycler 480 Real-Time PCR
system. Thermal cycling conditions were as recommended
by the manufacturer. The 2Δ ΔCT method was used to cal-
culate relative changes in gene expression determined from
these real time quantitative PCR experiments [18].
Physiological analysis of E. coli MKH13 clones in media
supplemented with NaCl
Each E. coli MKH13 clone expressing a different proP
homologue (ESA_02131, ESA_01706, ESA_04214, ESA_-
pESA3p05450, ESA_00673 or ESA_03328) was grown
overnight at 37°C in 10mls of LB, or minimal media sup-
plemented with the required components. The cells were
pelleted by centrifugation at 5,000 g, washed and resus-
pended in 200 μl ringers. The cell suspension was added
to the appropriate filter sterilized media with varying con-
centrations (0-10%) of added NaCl. Growth was moni-
tored in the relevant media over a 48 hour period and the
optical density (OD) was measured at 600 nm. Triplicate
readings were taken and graphs were constructed using
SigmaPlot 11.0.
Results
Functional complementation of E. coli MKH13 with
proP homologues
Each of the proP homologues were amplified using
primers with engineered cut sites flanking the gene of
interest. PCR products were digested and ligated to simi-
larly digested pUC18 plasmid. Each pUC18::proP plasmid
was transformed to MKH13 following passage through an
intermediate cloning host (DH5α). The osmosensitive E.
coli strain MKH13 was used to functionally screen each of
the proP homologues for their osmotolerance potential.
Unlike the parent strain, MC 4100, E. coli MKH13 is defi-
cient in the transport systems PutP, ProP and ProU; ren-
dering it incapable of growth in high osmolarity media
(≥4% added NaCl). Six of the seven proP homologues were
successfully transformed into E.coli MKH13 (ESA_01226
alone failed to be transformed and expressed in E.coli
MKH13, despite repeated transformation attempts). Suc-
cessful transformants were screened for osmotolerance
by plating on LB agar and on defined media agar plates
(supplemented with proline or glycine betaine to a finalconcentration of 1 mM) containing 4-10% added NaCl.
No colonies appeared following a control transform-
ation with pUC18 alone, while transformation efficien-
cies of ~60 CFU/μg DNA were achieved for each of
proP homologue constructs, with colonies appearing
within 72 hours at 37°C. Plasmids were extracted and
retransformed into E. coli MKH13 to confirm comple-
mentation and inserts were confirmed by PCR and se-
quence analysis.
proP expression analysis in C. sakazakii BAA-894
The level of gene expression was measured relative to
the constitutively expressed 16 s gene (ESA_03798). E.
coli MKH13 expressing proP homologues ESA_02131,
ESA_01706, ESA_04214, ESA_00673, ESA_03328 and
ESAp_3p05450 exhibited an increase in expression
levels in complex media (LB) following osmotic up-
shock with 6% NaCl (Figure 1). Strains expressing
ESA_02131 and ESA_04214 exhibited the highest in-
crease in expression 1 hour post initial osmotic shock
(19-fold and 47-fold increase respectively). However,
maximum levels of expression were reached 30 minutes
after initial osmotic shock in E. coli MKH13::01706 (3 fold
increase), E. coli MKH13::00673 (5 fold increase), E.coli
MKH13::03328 (2 fold increase) and E. coli MKH13::
pESA3p05450 (4 fold increase) (Table 3). This suggests a
biphasic response at the transcriptional level; a rapid low
level up regulation followed by a slower high level
response.
Physiological analysis of proP homologues expressed in
E. coli MKH13
Physiological analysis of each E. coli MKH13 strain trans-
formed with a proP homologue was performed to
Table 3 Molecular and physiological comparison of each ProP homologue
Gene locus tag Identity (%) Fold increase
in mRNA transcript















OD @ 600 nm
Growth
rate (hr−1)
ESA_02131 90 19.472 0.668 0.013 0.219 0.007 0.585 0.017
ESA_01706 40 2.854 0.259 0.000 0.205 0.008 0.358 0.011
ESA_04214 33 46.851 0.240 0.001 0.178 0.000 0.240 0.000
ESA_03328 30 1.598 0.255 0.003 0.261 0.021 0.397 0.021
ESA_00673 29 5.193 0.505 0.013 0.125 0.000 0.273 0.000
ESA_pESA3p05450 29 4.327 0.291 0.003 0.170 0.003 0.235 0.002
The % identity values were obtained in a previous study [11] and determined the homology of the above C. sakazakii putative proP genes relative to the well
characterised E. coli proP. Growth rate, OD and transcription values shown here were obtained when growth was monitored in 6% added NaCl.
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the heterologous host. Growth of E. coli MKH13 was
monitored over a 48 hour period in complex (LB) and de-
fined media with varying concentrations of NaCl (0-10%
added NaCl). E. coli MKH13 expressing the empty pUC18
vector was used as a negative control; failing to grow at
NaCl concentrations ≥4% added NaCl.
a) Growth in complex media at elevated osmolarity
Each of the six strains expressing a proP homologue
grew in LB broth supplemented with ≥ 4% added NaCl,
with the control strain (E. coli MKH13::pUC18) exhibit-
ing no growth. At the most discriminatory salt concen-
tration (6% added NaCl) growth was observed in five of
the strains tested but to varying degrees (Table 3). How-
ever, above 6% NaCl only strains expressing ESA_00673,
ESA_02131 and ESA_pESA3p05450 demonstrated an
ability to grow. ESA_00673 conferred the highest osmo-
tolerance with a growth rate of 0.007 h−1 at 8% NaCl
and a maximum OD of 0.57 @ 600 nm was recorded
after 12 hours incubation at 37°C. The next most osmo-
tolerant strains in complex media at elevated osmolarity
were those expressing ESA_02131 and the plasmid
encoded ESA_pESA3p05450. Both of these strains grew
in LB containing up to 7% added NaCl. At this concentra-
tion E. coli MKH13 expressing ESA_02131 demonstrated
a maximum OD of 0.29 after 22 hours incubation and a
growth rate of 0.009 h−1. Similarly the strain expressing
ESA_pESA3p05450 grew to a maximum OD of 0.27 after
11 hours and reached a growth rate of 0.003 h−1. While
each of the proP homologues tested conferred osmotoler-
ance in E. coli MKH13, it was observed that the strains ex-
pressing ESA_00673, ESA_02131 and ESA_pESA3p05450
demonstrated the highest levels of osmotolerance in an
osmolyte rich environment.
b) Growth in defined media plus proline at elevated osmolarity
Of the six strains tested, E. coli MKH13 expressing
ESA_02131, ESA_01706, ESA_03328 and ESA_pESA3p05450 demonstrated osmotolerance (growth above 4%
NaCl) in defined media supplemented with proline.
Each of the four osmotolerant strains grew to an OD ≥
0.17 at a NaCl concentration of 9%. E. coli MKH13 ex-
pressing ESA_02131 demonstrated the highest growth
rate of the osmotolerant strains (0.007 h−1), reaching a
final OD of 0.219 at 6% NaCl (Table 3). While the
growth rates of E. coli MKH13 expressing ESA_02131
in complex media are higher than those grown in de-
fined media supplemented with proline there is also a
significant difference in the maximum OD values re-
corded, with E. coli MKH13::ESA_02131 appearing to
favour the osmolyte rich environment over media where
proline is the only available compatible solute present.
c) Growth in defined media plus betaine at elevated osmolarity
While E. coli MKH13 expressing ESA_00673 failed to grow
above 4% NaCl, each of the five remaining strains demon-
strated osmotolerance in defined media supplemented with
betaine. E. coli MKH13::ESA_00673 also failed to grow
above 4% NaCl in defined media supplemented with 1 mM
proline but demonstrated an ability to grow in LB supple-
mented with 8% added NaCl. E. coli MKH13::04214 dem-
onstrated a growth rate of 0.013 h−1 at 5% NaCl in betaine
supplemented media but did not grow above 4% NaCl in
proline supplemented media. E. coli MKH13 expressing
ESA_02131, ESA_01706, ESA_03328 and ESA_pE-
SA3p05450 demonstrated the highest osmotolerance in de-
fined media supplemented with betaine, growing up to 9%
NaCl. However, significantly higher growth rates and/or
OD values were recorded for E. coli MKH13 expressing
ESA_02131, ESA_01706 and ESA_03328 when compared
to growth in proline supplemented media (Table 3).
Discussion
The adaptation of bacteria to increased osmotic stress
involves the intracellular accumulation of organic com-
pounds called osmolytes or compatible solutes (owing to
their compatibility with vital cellular processes at high
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compatible solutes is to increase cell turgor, thus coun-
terbalancing the external osmotic upshift and preventing
water loss, which left unchecked leads to plasmolysis
and ultimately cell death. The principal compatible sol-
utes accumulated by E. coli under osmotic stress condi-
tions are proline and betaine [22]. The osmoprotective
properties of proline were first described by Christian in
1955 who reported that the addition of this amino acid
to media at elevated osmolarity prevented bacterial
growth inhibition [23]. Likewise, the trimethylamino acid
glycine betaine has been extensively studied for its
osmoprotective properties [24]. Betaine and proline up-
take in E. coli is mediated primarily by the secondary up-
take system ProP [25].
Previous in silico analysis revealed 53 putative osmoto-
lerance loci on the C. sakazakii BAA-894 genome. Most
notably, seven homologues of the E. coli proP gene were
identified, each of which was believed to encode a trans-
membrane protein capable of transporting proline and/
or betaine [11]. Further analysis of each ProP homologue
revealed structural similarities to the E. coli ProP protein
with the gene encoding the most obvious ProP candidate
ESA_02131 (based on overall% identity), encoding the
characteristic 12 trans-membrane domains, an extended
central hydrophilic loop and a carboxy-terminal exten-
sion [11,26]. Interestingly, although the remaining six
proP homologues exhibit significant sequence identity,
they are all 60–70 amino acids shorter than ESA_02131
at the C-terminal end. Furthermore, the central hydro-
philic loop of the E. coli proP is extended and this is a
feature common to the protein encoded by the C. saka-
zakii ESA_02131 gene; however sequence analysis has
revealed that although a central hydrophilic loop is
present in each of the six additional proP homologues
this periplasmic loop is not extended to the same degree
as ESA_02131 (7–18 amino acids longer in ESA_02131
than other proP homologues identified).
In the current study we investigated the physiological
role, particularly in response to salt tolerance, of the
ProP porters identified previously in C. sakazaki. Firstly,
in order to determine if the proP homologues are upreg-
ulated at the transcriptional level in response to an os-
motic upshift, gene expression analysis was performed
using the C. sakazakii BAA-894 strain. Interestingly, all
six proP genes analyzed (ESA_02131, ESA_01706,
ESA_04214, ESA_00673, ESA_03328 and ESAp_3p05450)
demonstrated increased expression levels relative to the
constitutively expressed 16 s gene (ESA_03798) when
subject to an osmotic upshift; however expression levels
varied significantly amongst the individual proP homo-
logues (Figure 1). Surprisingly, the homologue which
exhibited the highest level of upregulation following os-
motic stress was not ESA_02131, the closest homologueto E. coli proP in terms of sequence identity, but rather
ESA_04214. If we consider that ProP activity in E. coli has
been shown to be regulated at the translational level via
ProQ, this may go some way to explaining this incongruity
[27]. ProQ is a cytoplasmic protein which was previously
believed to play a role in post-translational modification of
ProP; influencing the osmotic activation of this compatible
solute uptake protein [28,29]. However, more recently,
further analysis into the role of ProQ was warranted by
the fact that proP transcript levels are unchanged in a
proQ mutant, ProP expression is affected by deletion of
proQ and no physical interaction was detected between
ProP and ProQ [30]. As a result the role of ProQ was
recently clarified as a translational regulator of proP
mRNA. ProQ is a ribosome association protein, inter-
acting with proP mRNA transcribed from both RpoD
and RpoS promoters. As yet very little is known about
the mechanism of ProQ mediated translation, however
a deeper analysis of this protein has revealed a high affin-
ity RNA binding domain and an RNA strand exchange
and duplexing domain similar to the translational regulator
FinO [27,30]. It is likely that, as with E. coli, ProP mediated
osmotolerance is also regulated at the translational level in
C. sakazakii, a factor which may account for our observed
disconnect between transcriptional data and observed
osmotolerance phenotype as outlined below. In support
of this proposal, we have identified a ProQ homologue
(ESA_01419) on the C. sakazakii BAA-894 genome.
Physiological analysis of E.coli MKH13 transformed
with each C. sakazakii proP homologue reveals that six
of the proP homologues initially identified in silico play a
role in cellular osmoregulation in E. coli MKH13, a
strain which is deficient in the compatible solute trans-
porters putP, proP and proU rendering it sensitive to
hyperosmotic conditions. Significant differences in growth
rates were exhibited among strains grown in different en-
vironments where compatible solute availability varied. In
particular, E. coli MKH13 expressing ESA_01706 failed to
grow above 5% added NaCl when grown in LB (Figure 2),
yet in minimal media with proline as the only available
compatible solute this strain grew in the presence of up to
9% NaCl (growth rate of 0.005 h−1). If we consider that
competitive inhibition among osmolytes has been demon-
strated previously and the osmoprotective effects of osmo-
lytes varies significantly then these results are to be
expected [31,32]. Indeed, inhibition of glycine betaine up-
take by other compatible solutes, or indeed glycine betaine
analogues, is a phenomenon which has been observed pre-
viously [32]. Such structural similarities and differing osmo-
protective ranges may offer a plausable explanation for the
increased growth rates observed in this study in defined
media (where there is only one compatible solute - proline
or glycine betaine) in comparison to complex media rich in
‘competing’ osmoprotective compounds.
Figure 2 Determination of the osmotolerance of E. coli MKH13 strains transformed with proP homologues from C. sakazakii BAA-894
in A) complex media, B) defined media supplemented with proline and C) defined media supplemented with betaine.
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portance of the ProP porter to E. coli osmotolerance, we
are the first to demonstrate importance of ProP activity in
the osmotolerance of the neonatal pathogen C. sakzakii.
Indeed, each of the ProP porters analysed conferred osmo-
tolerance when expressed in E. coliMKH13, albeit to vary-
ing degrees depending on compatible solute availability.
Interestingly, glycine betaine appeared to be the most
osmoprotective compound outperforming proline. Five of
the strains expressing a proP homologue grew above 4%
NaCl in betaine supplemented media in comparison to
four strains demonstrating growth above 4% NaCl in pro-
line supplemented media. Furthermore, growth rates of E.
coli MKH13 expressing ESA_02131 and ESA_01706 were
significantly higher in media supplemented with glycine
betaine in comparison to proline (Table 3). Indeed it is
likely that some of the transporters may be demonstrating
specificity for one osmolyte over another but may trans-
port both due to the structural similarities of proline and
betaine. Another interesting finding was that ESA_00673
showed the highest osmotolerance of all the strains tested
in LB, yet did not grow above 4% NaCl in defined media
supplemented with either proline or glycine betaine sug-
gesting that this porter might well be transporting an as
yet unidentified osmolyte other than betaine or proline.
As outlined previously ESA_02131 was the most closely
related homologue to the well characterized proP of E. coli
and exhibited the characteristic C-terminal extension which
is lacking in the other C. sakazakii proP homologues. The
role of the carboxy-terminal extension in osmotolerance
was defined by Culham et al. [33] when a derivative with al-
terations to specific amino acids on the C-terminal exten-
sion required a larger osmotic upshift for activation, when
compared to the wild-type. The C-terminal domain has
been implicated in osmosensing by other transporters such
as BetP and OpuA in which osmolality controls the inter-
action of the C-terminal domain with each transporter,
switching the transporter between active and inactive
confirmations [34]. However, the C-terminal domain inProP does not appear to be required for activation of the
protein as orthologues without the coiled-coil domain of
the C-terminal extension still function as osmosensory
transporters [35]. That being said, research has shown that
a higher osmolality is required to activate transporters lack-
ing the coiled-coil [35]. The lack of this highly sensitive
coiled-coil domain in the C. sakazakii ProP homologues
may be a consequence of C. sakazakii existing in more
extreme osmotic environments when compared to E. coli
which depends on a single ProP which is highly tuned by
the coiled coil. Indeed Tsataski et al. [35] have previously
demonstrated that the osmotic activation of the transporter
ProP of E. coli is tuned by its C-terminal coiled-coil and os-
motically induced changes in the phospholipid composition.
Conclusion
In the current study we have confirmed that six of the previ-
ously identified proP homologues play a role in the osmoto-
lerance response of C. sakazakii. Gene expression analysis of
each of these proP homologues demonstrated an increase in
expression levels during an osmotic upshift. Furthermore,
heterologous expression against an osmotically sensitive E.
coli host revealed that each of the six homologues conferred
an osmotolerance phenotype, albeit to varying degrees, in
growth media with differences in osmolyte availability. The
degeneracy of ProP porters in C. sakazakii goes some way to
explaining the exteme osmotolerance phenotype of the bac-
terium, a factor which contributes significantly to its ability to
survive in PIF. To date ProP in E.coli has been well characte-
rized however this is the first study to demonstrate the im-
portance of ProP in C. sakazakii osmotolerance. Knowledge
of the transcriptional, translational and posttranslational
regulation of these uptake systems will aid the future design
and development of novel control stratagies for dealing with
the pathogen, particularly in foods destined for neonatal con-
sumption. Indeed, the use of small molecules to structurally
mimic compatible solutes (smugglin technology) may be a vi-
able alternative to antibiotics for the control of this pathogen
in high risk foods such as powdered infant formula [36-38].
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